Skip to main content
. 2018 Mar 5;24(3):323–331. doi: 10.1007/s13365-018-0615-7

Fig. 2.

Fig. 2

Reporting rates over time of confirmed PML cases per 100,000 patients with RA who received rituximab. Reporting rates of PML are based on estimated unique patient exposure. PML progressive multifocal leukoencephalopathy, RA rheumatoid arthritis